Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery

Anesthesiology

Volumn 104, Issue 6, 2006, Pages 1337-1339

  Deogaonkar, Anupa ^a   Deogaonkar, Milind ^b   Lee, John Y K ^b   Ebrahim, Zeyd ^c   Schubert, Armin ^d,e  

^a Division of Anesthesiology and Critical Care Medicine   (United States)

^b Center for Neurological Restoration   (United States)

^c Department of General Anesthesiology ^*  (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; DEXMEDETOMIDINE; LEVODOPA; MIDAZOLAM; PRAMIPEXOLE; PROPOFOL;

ADULT; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CASE REPORT; CONSTIPATION; DYSKINESIA; HUMAN; MALE; MICROELECTRODE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

DEEP BRAIN STIMULATION; DEXMEDETOMIDINE; DYSKINESIA, DRUG-INDUCED; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROPOFOL;

EID: 33744955097     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200606000-00029     Document Type: Article

References (35)

1. Deogaonkar M, Subramanian T: Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease. Brain Res Brain Res Rev 2005; 50:156-68
2. Krauss JK, Akeyson EW, Giam P, Jankovic J: Propofol-induced dyskinesias in Parkinson's disease. Anesth Analg 1996; 83:420-2
3. Borgeat A, Wilder-Smith O: Acute choreoathetoid reaction to propofol (letter). Anaesthesia 1991; 46:797
4. Diltoer MW, Rosseneu S, Ramet J, De Wolf D, Spapen HD, De Turck BJ, Huyghens LP: Anticholinergic treatment for choreoathetosis in a child after induction with propofol (letter). Anesth Analg 1996; 82:670
5. Stolarek IH, Ford MJ: Acute dystonia induced by midazolam and abolished by flumazenil. BMJ 1990; 300:614
6. Davies A: Midazolam-induced dyskinesia. Palliat Med 2000; 14:435-6
7. Reddy RV, Moorthy SS, Dierdorf SF, Deitch RD, Link L Jr: Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77:1008-11
8. Bouly A, Nathan N, Feiss P: Propofol in myotonic dystrophy (letter). Anaesthesia 1991; 46:705
9. Fleming JA: Propofol: Rational and accurate reporting (letter). Anaesth Intensive Care 1993; 21:885-6
10. McHugh P: Acute choreoathetoid reaction to propofol (letter). Anaesthesia 1991; 46:425
11. Borgeat A, Dessibourg C, Popovic V, Meier D, Blanchard M, Schwander D: Propofol and spontaneous movements: An EEG study. ANESTHESIOLOGY 1991; 74:24-7
12. Parkinson Study Group: Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996; 39:37-45
13. Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, Rodriguez ME, Martinez-Lage JM: Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989; 39:11-9
14. Muenter MD, Sharpless NS, Tyce GM, Darley FL: Patterns of dystonia ("I-D-I" and "D-I-D-") in response to 1-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977; 52:163-74
15. Calon F, Di Paolo T: Levodopa response motor complications: GABA receptors and preproenkephalin expression in human brain. Parkinsonism Relat Disord 2002; 8:449-54
16. Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T: Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Mov Disord 2003; 18:241-53
17. Irifune M, Takarada T, Shimizu Y, Endo C, Katayama S, Dohi T, Kawahara M: Propofol-induced anesthesia in mice is mediated by gamma-aminobutyric acid-A and excitatory amino acid receptors. Anesth Analg 2003; 97:424-9
18. Marik PE: Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004; 10:3639-49
19. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M: The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002; 5:979-84
20. Bieda MC, MacIver MB: Major role for tonic GABAA conductances in anesthetic suppression of intrinsic neuronal excitability. J Neurophysiol 2004; 92:1658-67
21. Kitamura A, Marszalec W, Yeh JZ, Narahashi T: Effects of halothane and propofol on excitatory and inhibitory synaptic transmission in rat cortical neurons. J Pharmacol Exp Ther 2003; 304:162-71
22. Peduto VA, Concas A, Santoro G, Biggio G, Gessa GL: Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. ANESTHESIOLOGY 1991; 75:1000-9
23. Ying SW, Goldstein PA: Propofol-block of SK channels in reticular thalamic neurons enhances GABAergic inhibition in relay neurons. J Neurophysiol 2005; 93:1935-48
24. Stover JF, Kempski OS: Anesthesia increases circulating glutamate in neurosurgical patients. Acta Neurochir (Wien) 2005; 147:847-53
25. Weigt HU, Georgieff M, Beyer C, Fohr KJ: Activation of neuronal N-methyl-D-aspartate receptor channels by lipid emulsions. Anesth Analg 2002; 94:331-7
26. Papa SM, Chase TN: Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol 1996; 39:574-8
27. Ard J, Doyle W, Bekker A: Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003; 15:263-6
28. Ard JL Jr, Bekker AY, Doyle WK: Dexmedetomidine in awake craniotomy: A technical note. Surg Neurol 2005; 63:114-6
29. Bekker A, Sturaitis MK: Dexmedetomidine for neurological surgery. Neurosurgery 2005; 57:1-10
30. Bekker AY, Kaufman B, Samir H, Doyle W: The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001; 92:1251-3
31. Thornton C, Lucas MA, Newton DE, Dore CJ, Jones RM: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers: II. Auditory and somatosensory evoked responses. Br J Anaesth 1999; 83:381-6
32. Bloom M, Beric A, Bekker A: Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthesiol 2001; 13:320-2
33. Li BH, Lohmann JS, Schuler HG, Cronin AJ: Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg 2003; 96:1155-60
34. Haapalinna A, Leino T, Heinonen E: The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Naunyn Schmiedebergs Arch Pharmacol 2003; 368:342-51
35. Huotari M, Kukkonen K, Liikka N, Potasev T, Raasmaja A, Mannisto PT: Effects of histamine H(3)-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats. Parkinsonism Relat Disord 2000; 6:159-64